DUBLIN, Nov. 20, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/sxkxd8/2016_u_s_genetic) has announced the addition of the "2016 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies" report to their offering.
This new study contains 430 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.
- Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers.
U.S. Market Overview
- Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment. - Five-year test volume and sales projections.
Market Segmentation Analysis
- Five-year test volume and sales projections: - Infectious Diseases - Forensic Testing - Cancer - Paternity Testing/HLA Typing - Genetic Diseases - Others
- Abbott- Affymetrix- Agilent Technologies- Applied Gene Technologies- Arca Biopharma- Beckman Coulter/Danaher- Becton Dickinson- Biokit- bioMerieux- Bio-Rad- Biotest- Cepheid- CellMark Forensics/LabCorp- Decode Genetics- Diadexus- Eiken- Elitech Group- Enzo- Exact Sciences- Fujirebio- Grifols- Proteome Sciences- Qiagen- Roche- Scienion- Sequenom- Shimadzu- Siemens- Sierra Molecular- Takara Bio- Tecan Group- Thermo Fisher
For more information visit http://www.researchandmarkets.com/research/sxkxd8/2016_u_s_genetic
Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets